Marijuana for Trauma Inc. announced that is has begun a lawsuit against OrganiGram Holdings Inc. (TSXV:OGI), whose wholly owned subsidiary OrganiGram Inc. is a licensed medical marijuana producer in Canada.
As quoted in the press release:

The lawsuit was filed with the Court of Queen’s Bench of New Brunswick, Judicial District of Fredericton for: breach of confidence, conversion, breach of contract, conspiracy and breach of trust, breach of fiduciary duty, and negligent misrepresentation.
The lawsuit alleges OrganiGram denied MFT its interest in Trauma Healing Centers Inc. (THC).  THC, developed through a partnership between MFT, OrganiGram and Denis Arsenault, CEO of OrganiGram and also a Defendant in the lawsuit, opened centres in several cities in eastern Canada to provide services to those suffering from post-traumatic stress disorder (PTSD) and other chronic conditions caused by trauma. MFT alleges that OrganiGram unlawfully terminated the relationship, unlawfully used MFT’s proprietary information, business practices, and expansion plans for MFT.  Following the termination of the relationship in February 2015, THC moved to restrict MFT from helping veterans and first responders outside of New Brunswick.


Fabian Henry, president of Marijuana for Trauma, commented:

We had an agreement with OrganiGram and Denis Arsenault to expand our services assisting veterans suffering from PTSD. The agreement was supposed to create a seamless experience for approved clients in need of a referral to a licensed medical marijuana producer.  The termination of our business arrangement and subsequent use of our business and expansion plans is unlawful and will affect our ability to help hundreds of veterans.

Click here to read the full Marijuana for Trauma press release.

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less